Cosmetics

China cosmetics efficacy claims FAQ is available to help answer cosmetics manufacturers and ingredient suppliers’ questions.

China cosmetics GMP inspection points and judgment principles came into force on December 1, 2023, to provide guidance to the industry.

Cosmetics enterprises quality and safety responsibilities have been addressed in the draft regulation issued by the NMPA on Nov. 29, 2022.

Cosmetics adverse reactions collection and reporting draft guidelines for registrants and filers (trial) are formulated according to the CSAR

China cosmetics filing FAQs is a publication first issued by the Beijing Municipal Medical Products Administration (MPA) in November 2021.

China cosmetics registrations FAQS October 2022 covers raw materials, labelling, DRA powers of attorney etc.

China personalized cosmetics services pilot run will be carried out by the Beijing, Shanghai, Zhejiang, Shandong and Guangdong MPAs

China has introduced a new Catalogue on the Import and Export of Endangered Species to implement its commitment to CITES.

A Cosmetics Adverse Reaction Monitoring System has been launched in China to strengthen & improve the efficiency of monitoring nationwide

The medtech, cosmetics and pharmaceutical webinars will cover important China regulatory updates presented by our Cisema regulatory experts.

China cosmetics registration certificates for special cosmetics and new cosmetic ingredients will be issued electronically from Oct. 1, 2022

NMPA has issued draft measures for the supervision and administration of China cosmetics online operations